Rhumbline Advisers Sorrento Therapeutics, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $35,839 - $88,630	48,432 Added 8.69%	606,023 $537,000
Q3 2022 Nov 10, 2022	BUY	$1.51 - $2.88 $52,439 - $100,016	34,728 Added 6.64%	557,591 $875,000
Q2 2022 Aug 11, 2022	BUY	$1.24 - $2.33 $264,319 - $496,665	213,161 Added 68.83%	522,863 $1.05 Million
Q1 2022 May 12, 2022	BUY	$2.0 - $4.9 $10,594 - $25,955	5,297 Added 1.74%	309,702 $722,000
Q4 2021 Feb 10, 2022	BUY	$4.65 - $7.23 $26,286 - $40,871	5,653 Added 1.89%	304,405 $1.42 Million
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $54,352 - $80,611	7,335 Added 2.52%	298,752 $2.28 Million
Q2 2021 Aug 05, 2021	BUY	$6.35 - $10.0 $56,534 - $89,030	8,903 Added 3.15%	291,417 $2.82 Million
Q1 2021 May 06, 2021	SELL	$7.03 - $16.51 $80,971 - $190,162	-11,518 Reduced 3.92%	282,514 $2.34 Million
Q4 2020 Feb 10, 2021	BUY	$5.76 - $11.95 $258,353 - $535,993	44,853 Added 18.0%	294,032 $2.01 Million
Q3 2020 Nov 12, 2020	SELL	$6.17 - $18.82 $86,885 - $265,023	-14,082 Reduced 5.35%	249,179 $2.78 Million
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $173,512 - $678,000	100,296 Added 61.54%	263,261 $1.65 Million
Q1 2020 May 06, 2020	SELL	$1.57 - $4.76 $1,270 - $3,850	-809 Reduced 0.49%	162,965 $300,000
Q4 2019 Feb 05, 2020	BUY	$1.45 - $4.17 $10,147 - $29,181	6,998 Added 4.46%	163,774 $554,000
Q3 2019 Oct 23, 2019	BUY	$2.05 - $2.69 $2,337 - $3,066	1,140 Added 0.73%	156,776 $336,000
Q2 2019 Aug 14, 2019	BUY	$2.67 - $4.38 $43,221 - $70,903	16,188 Added 11.61%	155,636 $416,000
Q1 2019 May 01, 2019	BUY	$1.86 - $5.94 $3,368 - $10,757	1,811 Added 1.32%	139,448 $662,000
Q4 2018 Jan 31, 2019	BUY	$2.01 - $4.24 $108,684 - $229,265	54,072 Added 64.71%	137,637 $330,000
Q3 2018 Nov 07, 2018	BUY	$4.22 - $7.5 $16,344 - $29,047	3,873 Added 4.86%	83,565 $368,000
Q2 2018 Aug 06, 2018	BUY	$4.75 - $8.0 $378,537 - $637,536	79,692 New	79,692 $574,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account